Companies / kingfriend-603707

Kingfriend (603707)

ChinaIndustrial & Manufacturing

Overview

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. It also provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium besylate, cisatracurium, calcium folinate, doxorubicin, milrinone, bleomycin, carboplatin, cytarabine, topotecan hydrochloride, phenylephrine hydrochloride, ganirelix acetate, furosemide, glycopyrrolate, neostigmine methylsulfate, succinylcholine chlor

Employees1558
Market Cap$12.8B
Revenue$4.0B
Listed OnShanghai Stock Exchange
Ticker603707
CEOMr. Tang Yongqun
HeadquartersNanjing

Website

https://www.nkf-pharma.com